论文部分内容阅读
Selective androgen receptor modulators for the treatment of late onset male hypogonadism
【机 构】
：
GTx, Inc., Memphis, Tennessee, USA
【出 处】
：
亚洲男性学杂志（英文版）
【发表日期】
：
2014年2期
其他文献
Men with castration-resistant prostate cancer exhibit resistance to chemotherapeutic agents such as Docetaxel.Defining the mechanisms of resistance to Docetaxel is critical for treating advanced disease.In a new study,Carlos Cordon-Cardo and colleagues de
期刊
The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population
Two-stage urethroplasty is a better choice for proximal hypospadias with severe chordee after urethr
It is still debatable whether single? or two?stage urethroplasty is a more suitable technique for treating hypospadias with severe chordee after urethral plate transection. This retrospective study evaluated these two techniques. A total of 66 patients of
Immunotherapy and therapeutic vaccines in prostate cancer:an update on current strategies and clinic
In recent years, immunotherapy has emerged as a viable and attractive strategy for the treatment of prostate cancer. While there are multiple ways to target the immune system, therapeutic cancer vaccines and immune checkpoint inhibitors have been most suc
In the late stage of spermatogenesis (i.e.,spermiogensis),chromatin becomes tightly packed by the replacement ofhistones to protamines via transition proteins.This process is essential for the capitulation of fertility and brings about not only dynamic ch
期刊